ISU-101

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameISU-101
Drug Alias NameEGFR-targeting antibody (Isu Abxis/Scancell)high affinity SC-100 (Isu Abxis/Scancell)ISU-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeSouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIsu Abxis Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScancell LtdIsu Abxis Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A